📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Cardiac Insight

1.1 - Company Overview

Cardiac Insight Logo

Cardiac Insight

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of body-worn ECG sensing technology, including Cardea SOLO, a wearable ambulatory ECG for up to seven days of continuous heart rhythm monitoring with in-office data analysis, and Cardea 20/20 ECG, an automated 12-lead ECG system designed to detect cardiovascular issues in young athletes using International Consensus Criteria.

Products and services

  • Cardea 20/20 ECG: An automated 12-lead ECG system architected to detect cardiovascular issues in young athletes using International Consensus Criteria for assessments, standards-aligned
  • Cardea SOLO: A wearable ambulatory ECG device engineered for continuous heart rhythm monitoring over seven days with facilitated in-office data analysis, ambulatory-grade
  • Body-worn ECG sensing technology: Cardiac Insight delivers wearable electrocardiogram sensing technology for on-body ECG data capture, body-worn

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Cardiac Insight

Celladon Logo

Celladon

HQ: United States Website
  • Description: Provider of biotechnology focused on developing molecular therapies for the treatment of heart failure.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Celladon company profile →
R3 Vascular Logo

R3 Vascular

HQ: United States Website
  • Description: Provider of medical devices for peripheral artery disease, including the MAGNITUDE Bioresorbable Sirolimus-Eluting Scaffold (BRS), which maintains vessel support, delivers sirolimus to prevent restenosis, and gradually resorbs into tissue.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full R3 Vascular company profile →
JenaValve Logo

JenaValve

HQ: United States Website
  • Description: Provider of transcatheter heart valve solutions, including the Trilogy Heart Valve System for TAVR to treat severe aortic regurgitation or stenosis, featuring a self-expanding nitinol frame and locator technology for precise placement. Offers the Trilogy Valve for secure anchoring without calcium, a Delivery System for precise deployment, and an 85cm pre-shaped Introducer Sheath for safe vascular access.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full JenaValve company profile →
Portola Pharmaceuticals Logo

Portola Pharmaceuticals

HQ: United States Website
  • Description: Provider of biopharmaceutical therapeutics, discovering and developing treatments for acute and chronic cardiovascular and autoimmune/inflammatory diseases, including PRT054021, an oral factor Xa inhibitor for prevention and treatment of deep vein thrombosis and pulmonary embolism after orthopedic.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Portola Pharmaceuticals company profile →
Kardium Logo

Kardium

HQ: Canada Website
  • Description: Provider of the Globe Pulsed Field System for the diagnosis and treatment of atrial fibrillation, integrating pulmonary vein isolation, high-definition mapping, and atrial ablation in a single catheter. Offers the Globe PF Mapping and Ablation System with a 122-electrode catheter, the Globe Catheter (30 mm spherical array, 122 electrodes), and the PULSAR clinical study evaluating safety and effectiveness.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Kardium company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Cardiac Insight

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Cardiac Insight

2.2 - Growth funds investing in similar companies to Cardiac Insight

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Cardiac Insight

4.2 - Public trading comparable groups for Cardiac Insight

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Cardiac Insight

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Cardiac Insight

What does Cardiac Insight do?

Cardiac Insight is a provider of body-worn ECG sensing technology, including Cardea SOLO, a wearable ambulatory ECG for up to seven days of continuous heart rhythm monitoring with in-office data analysis, and Cardea 20/20 ECG, an automated 12-lead ECG system designed to detect cardiovascular issues in young athletes using International Consensus Criteria.

Who are Cardiac Insight's competitors?

Cardiac Insight's competitors and similar companies include Celladon, R3 Vascular, JenaValve, Portola Pharmaceuticals, and Kardium.

Where is Cardiac Insight headquartered?

Cardiac Insight is headquartered in United States.

How many employees does Cardiac Insight have?

Cardiac Insight has 1,000 employees 🔒.

When was Cardiac Insight founded?

Cardiac Insight was founded in 2010 🔒.

What sector and industry vertical is Cardiac Insight in?

Cardiac Insight is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Cardiac Insight

Who are the top strategic acquirers in Cardiac Insight's sector and industry

Top strategic M&A buyers and acquirers in Cardiac Insight's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Cardiac Insight?

Top strategic M&A buyers groups and sectors for Cardiac Insight include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Cardiac Insight's sector and industry vertical

Which are the top PE firms investing in Cardiac Insight's sector and industry vertical?

Top PE firms investing in Cardiac Insight's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Cardiac Insight's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Cardiac Insight's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Cardiac Insight's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Cardiac Insight include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Cardiac Insight's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Cardiac Insight?

The key public trading comparables and valuation benchmarks for Cardiac Insight include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Cardiac Insight for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Cardiac Insight with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Cardiac Insight's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Cardiac Insight with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Cardiac Insight's' sector and industry vertical?

Access recent funding rounds and capital raises in Cardiac Insight's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Cardiac Insight

Launch login modal Launch register modal